Skip to main content
Clinical Trials/NCT05295511
NCT05295511CompletedNot Applicable

Dose-response Effects of a Recreational Team Handball-based Exercise Programme on Cardiovascular, Metabolic, Musculoskeletal and Physical Fitness Markers in Inactive Middle-aged and Older Male

University Institute of Maia1 site in 1 country68 target enrollmentStarted: December 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
68
Locations
1
Primary Endpoint
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake

Study Overview

Brief Summary

The present study aims at analyzing the dose-response effects of a recreational team handball-based exercise programme on cardiovascular, metabolic, musculoskeletal and physical fitness markers of inactive middle-aged and older men, without previous experience with the sport. The researchers hypothesized a positive weekly training frequency effect on health and physical fitness outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Male participants; inactive with 50 or more years of age (i.e., not complying with the physical activity guidelines for the last 6 months).

Exclusion Criteria

  • •Any medical contraindication to perform moderate-to-vigorous physical activity; incapacity to run or grip a ball.

Arms & Interventions

Team Handball 1

Experimental

Team handball group participants were instructed to perform one weekly 60-min recreational team handball training sessions for 16 weeks.

Intervention: Recreational Team Handball programme (Other)

Team Handball 2

Experimental

Team handball group participants were instructed to perform two weekly 60-min recreational team handball training sessions for 16 weeks.

Intervention: Recreational Team Handball programme (Other)

Team Handball 3

Experimental

Team handball group participants were instructed to perform three weekly 60-min recreational team handball training sessions for 16 weeks.

Intervention: Recreational Team Handball programme (Other)

Control Group

No Intervention

The control group participants were instructed to keep their regular daily physical activity for 16 weeks.

Outcomes

Primary Outcomes

Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake

Time Frame: Baseline and week 16

Maximal oxygen uptake (mL/min/kg) was measured by pulmonary gas exchange measurements. The participants performed an incremental treadmill test until voluntary exhaustion in a laboratory, according to a standardized incremental protocol.

Secondary Outcomes

  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in systolic blood pressure(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in diastolic blood pressure(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in resting heart rate(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in carboxy-terminal type-1 collagen crosslinks(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in sclerostin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total antioxidant status(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in low-density lipoprotein cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione peroxidase(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in procollagen type-1 amino-terminal propeptide(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in isometric upper body strength(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in triglycerides(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione reductase(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in postural balance(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in aerobic performance(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in high-density lipoprotein cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glycosylated haemoglobin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in osteocalcin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in upper and lower body strength, and coordination(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glucose(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in insulin(Baseline and week 16)

Investigators

Sponsor
University Institute of Maia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Susana Cristina Araújo Póvoas

Associate Professor

University Institute of Maia

Study Sites (1)

Loading locations...

Similar Trials